Important Pharmacokinetic Properties of Antiepileptic Drugs

Epilepsia

Volumn 36, Issue , 1995, Pages S1-S7

  Bourgeois, Blaise F D ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Anticonvulsants; Antiepileptic agents; Biological availability; Biopharmaceu tics; Clinical trials; Drug interactions; Drug monitoring; Drug toxicity; Epilepsy; Pharmacokinetics

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

BIOTRANSFORMATION; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; EPILEPSY; HUMAN; HUMAN TISSUE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACETIC ACIDS; ANTICONVULSANTS; BIOLOGICAL AVAILABILITY; BIOPHARMACEUTICS; CARBAMAZEPINE; DRUG INTERACTIONS; EPILEPSY; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HALF-LIFE; HUMAN; INTESTINAL ABSORPTION; TRIAZINES; VIGABATRIN;

EID: 0028864135     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1995.tb06004.x     Document Type: Article

References (17)

1. Explanation of dose‐dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis‐Menten equation
2. Pharmacokinetics and pharmacodynamics in clinical practice.
3. Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administration
4. γ‐Vinyl GAB A (4‐amino‐hex‐5‐enoic acid), a new selective irreversible inhibitor of GABA‐T: effects on brain GABA metabolism in mice
5. The delayed effect of sodium valproate on the photo‐convulsive response in man
6. Cytochrome P450 isozymes and antiepileptic drug interactions
7. Problems of combination drug therapy in children
8. Effects of carbamazepine on phenytoin pharmacokinetics determined by stable isotope technique
9. Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy
10. Valproate: interactions with other drugs.
11. Variable free and total valproic acid concentrations in sole‐ and multidrug therapy
12. Summary of Neurontin (gabapentin) clinical pharmacokinetics [Abstract]
13. Clinical pharmacokinetics of gabapentin.
14. Lamotrigine: single dose pharmacokinetics and initial one week exposure in refractory seizures
15. Double‐blind crossover trial of lamotrigine (Lamictal) as add‐on therapy in intractable epilepsy
16. GABA in epilepsy: the pharmacologic basis
17. Oxcarbazepine: a review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders